CAROLINE MOORE: Open Payments
NPI 1205460177 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 32 payments from 15 companies in 2025. Trend: 2023 $205 · 2024 $708 · 2025 $973
Food & beverage: $904Education: $69
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $232 |
| ABBVIE INC. | 11 | $230 |
| Amgen Inc. | 1 | $139 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $87 |
| Organon LLC | 4 | $57 |
| GENZYME CORPORATION | 2 | $44 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $36 |
| UCB, Inc. | 1 | $23 |
| Organogenesis Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
Products named: Opzelura, RINVOQ, OTEZLA, SKYRIZI, DUPIXENT, Cabtreo, VTAMA, Bimzelx.
Industry payments across NJ — which companies pay providers there.
